Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) Myeloid differential protein-2 (MD2) has been shown to play
a critical role in the progression
to experimentally verify the feasibility of testing technologies as
a factor that increases the motivation
[Figure not available: see fulltext.]
A procedure for the preparation of an adduct
Thymidylate synthase (ThS) is
a target for antimetabolite antitumor drugs. Such drugs have been
BAO, Z.,
HAN, Z.,
ZHANG, B.,
YU, Y.,
XU, Z.,
MA, W.,
DING, F.,
ZHANG, L.,
YU, M.,
LIU, S.,
JIN, M.,
YAN, G.,
HUANG, Q.,
WANG, X.,
HUA, B.,
YANG, F.,
LI, Y.,
LIU, Y.,
LI, B.,
WANG, N.,
CAI, B.,
ZAGIDULLIN, N.,
CARVALHO, K. (2019) ATOonhumancardiacdevelopmentbyusingavitrocardiacdifferentiationmodel ofhumaninducedpluripotentstemcells(hiPSCs).Herewefoundthatclinicallyachievableconcentrations(0.1, 0.5 and 1μM) of ATO resulted in
a development taken as
a whole; the verification of rational educational strategies. The discussed problem